INmune Bio Inc. revenue for the last year amounted to 155.00 k USD, the most of which — 155.00 k USD — came from its highest performing source at the moment, INKmune and DN-TNF Product Platform, the year earlier bringing 374.00 k USD. The greatest contribution to the revenue figure was made by United States — last year it brought INmune Bio Inc. 155.00 k USD, and the year before that — 374.00 k USD.